Lansdowne Partners (UK)’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,259
Closed -$119K 36
2023
Q3
$119K Buy
+12,259
New +$119K 0.01% 35